Role of Trk Receptors in the Development and Function of Non-neuronal Structures

Division Of Basic Sciences - Nci

Investigators

Linked publications & trials

Abstract

Truncated Trk receptor isoforms lacking the kinase domain are abundantly expressed during development and in the adult; however, their function and signaling capacity is largely unknown. Recently, we have investigated whether TrkB Receptors have other functions outside the nervous system. We found that a novel unexpected role of BDNF in regulating the cardiac contraction force independent of the nervous system innervation. This function is mediated by the truncated TrkB.T1 receptor expressed in cardiomyocytes. Loss of TrkB.T1 in these cells impairs calcium signaling and causes cardiomyopathy. TrkB.T1 is activated by BDNF produced by cardiomyocytes suggesting an autocrine/paracrine loop. These findings unveil a novel signaling mechanism in the heart that is activated by BDNF and provide evidence for a global role of this neurotrophin in the homeostasis of the organism by signaling through different TrkB receptor isoforms. Moreover, we are investigating whether activation of TrkB.T1 by BDNF has a protective role during genetic or drug-induced cardiac injury. For example, we have crossed our TrkB.T1 deficient mice with a distrophic mouse model to investigate whether loss of TrkB.T1 worsen the cardiac deficit caused by the mutant dystrophin gene. Moreover, we are testing whether doxorubicin-induced cardiac toxicity is affected by loss of TrkB.T1/BDNF signaling. BDNF signaling in neuronal hypothalamic circuitries regulates mammalian food intake. Whether BDNF signaling exerts metabolic effects on peripheral organs is currently unclear. We recently found that the BDNF receptor TrkB.T1 is expressed by pancreatic beta-cells where it regulates insulin release. Consequently, mice lacking this receptor show impaired glucose tolerance and insulin secretion. BDNF binding to beta-cells TrkB.T1 triggers calcium release from intracellular stores, increasing glucose-induced insulin secretion. In addition, BDNF is secreted by skeletal muscle and knocking out BDNF in skeletal muscle of mice phenocopies the metabolic impairments caused by TrkB.T1 deletion in beta-cells. The finding that BDNF also induces insulin secretion in human islets via TrkB.T1, identifies a new unexpected regulatory function of BDNF on metabolism that is independent of CNS activity. Our data suggest that muscle derived BDNF may be a key factor mediating increased glucose metabolism in response to exercise, with implications for the treatment of diabetes and related metabolic diseases.